{"id":"W2113528374","doi":"10.1080/14653240600735743","title":"Testing the safety of clinical-grade mature autologous myeloid DC in a phase I clinical immunotherapy trial of CML","year":2006,"lang":"en","type":"article","venue":"Cytotherapy","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":false,"ca_institutions":"","funders":"National Cancer Institute; University of Saskatchewan; Mayo Clinic","keywords":"Medicine; Clinical trial; Immunotherapy; Imatinib mesylate; Internal medicine; Imatinib; Oncology; Immunology; Myeloid leukemia; Cancer","routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002356373,0.0003121995,0.001540882,0.0001253928,0.00005880023,0.000008914714,0.0003270386,0.0004500592,0.0001560708],"category_scores_gemma":[0.0005912637,0.0002033737,0.0005686803,0.0005506483,0.0005388958,0.00005095649,0.00002976821,0.0007331141,0.0000105056],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000202673,"about_ca_system_score_gemma":0.0008665365,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004419142,"about_ca_topic_score_gemma":0.00004554739,"domain_scores_codex":[0.9953007,0.0005655385,0.002839387,0.0004839163,0.0004267112,0.000383752],"domain_scores_gemma":[0.9953959,0.002328961,0.00103887,0.00102472,0.0001287652,0.00008281007],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.224115,0.01581004,0.1970349,0.0001419055,0.001099573,0.0002042428,0.0005857809,0.00005801845,0.04018556,0.000597398,0.002225909,0.5179417],"study_design_scores_gemma":[0.544569,0.008582972,0.4195758,0.0004434881,0.0001709497,0.00009391444,0.00009615559,0.0006473541,0.00508794,0.0008889589,0.01951168,0.0003318327],"study_design_candidate":"randomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9925757,0.002128875,0.0001001873,0.001052864,0.0005155728,0.00181459,0.00004205664,0.00006828491,0.001701887],"genre_scores_gemma":[0.9922386,0.000975222,0.004686403,0.0005953009,0.0009266749,0.0000566575,0.00004130966,0.00007256278,0.0004072044],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.5176098,"threshold_uncertainty_score":0.829334,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.07013701845711165,"score_gpt":0.4027963537630941,"score_spread":0.3326593353059825,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}